Table 4. Relative plasma metabolite concentrations for antioxidants, markers of oxidation and inflammation, methylated metabolites, TCA cycle, and urea cycle intermediates in healthy cats (H cats) and chronic kidney disease (CKD) cats at baseline (after feeding pretrial food1 for 14 days) and after feeding Food A2 (containing scFOS) or Food B3 (containing apple pomace) as fiber sources for 4 weeks each.
Mean Values* | Group Effect‡ | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
H Cats | CKD Cats | Overall Effect of Health | Overall Effect of Both Treatments | H Cats: Treatment with Food B versus Food A¥ | CKD Cats: Treatment with Food B versus Food A¥ | Overall Effect of Interaction | |||||
Metabolites | BSL | Food A | Food B | BSL | Food A | Food B | P-value | P-value | P-value | P-value | P-value |
Tocopherol Metabolism | |||||||||||
α-tocopherol | 0.99 | 0.97 | 1.05§ | 0.90 | 0.91 | 0.95 | 0.08 | 0.04 | 0.01 | 0.62 | 0.28 |
α-CEHC sulfate | 0.95 | 0.93 | 1.13 | 1.63 | 3.12§ | 2.48 | 0.78 | 0.36 | 0.46 | 0.43 | 0.08 |
γ-tocopherol/β-tocopherol | 1.75# | 0.84§ | 1.49 | 1.18# | 0.79§ | 1.15 | 0.03 | 0.000 | 0.002 | 0.08 | 0.43 |
Glutathione Metabolism | |||||||||||
oxidized glutathione (GSSG) | 0.83 | 1.34§ | 1.03 | 1.20 | 0.97 | 1.58 | 0.41 | 0.26 | 0.21 | 0.03 | 0.02 |
Cysteine-glutathione disulfide | 0.88 | 1.12§ | 0.97 | 0.99 | 0.99 | 1.23§ | 0.31 | 0.01 | 0.04 | 0.012 | 0.005 |
cysteinylglycine | 0.68 | 1.41§ | 1.09§ | 1.15 | 1.33 | 1.84 | 0.32 | 0.03 | 0.74 | 0.34 | 0.42 |
cysteinylglycine disulfide | 0.72 | 1.06§ | 1.01§ | 0.85 | 1.10§ | 1.22§ | 0.12 | 0.000 | 0.58 | 0.15 | 0.27 |
5-oxoproline | 0.93 | 0.98 | 0.92 | 1.11 | 1.13 | 1.10 | 0.03 | 0.38 | 0.13 | 0.77 | 0.44 |
2-aminobutyrate | 0.77 | 1.12§ | 1.28§ | 0.73 | 1.00§ | 1.06§ | 0.49 | 0.000 | 0.16 | 0.53 | 0.40 |
2-hydroxybutyrate/2-hydroxyisobutyrate | 0.89 | 1.40§ | 1.39§ | 1.44 | 1.76§ | 1.72§ | 0.45 | 0.000 | 0.76 | 0.91 | 0.13 |
Ophthalmate | 0.27 | 0.96§ | 0.93§ | 0.93 | 2.07§ | 1.17§ | 0.12 | 0.000 | 0.52 | 0.17 | 0.72 |
Sphingolipid Metabolism | |||||||||||
Sphinganine | 0.81 | 2.55§ | 1.02 | 1.10 | 1.30 | 2.65§ | 0.28 | 0.004 | 0.003 | 0.012 | 0.001 |
sphinganine-1-phosphate | 0.93 | 2.66§ | 0.95 | 1.08 | 1.28 | 3.24§ | 0.58 | 0.01 | 0.002 | 0.019 | 0.001 |
Sphingosine | 0.80 | 2.92§ | 0.99 | 1.01 | 1.21 | 2.84§ | 0.20 | 0.005 | 0.004 | 0.008 | 0.001 |
sphingosine 1-phosphate | 0.89 | 1.71§ | 0.95 | 0.93 | 1.03 | 1.84§ | 0.63 | 0.01 | 0.007 | 0.009 | 0.001 |
sphingadienine | 0.93 | 2.20§ | 0.91 | 0.99 | 1.10 | 2.12§ | 0.56 | 0.03 | 0.001 | 0.005 | 0.000 |
Glycine, Serine, & Threonine Metabolism | |||||||||||
Glycine | 0.94# | 1.00§ | 0.98 | 1.13# | 1.10 | 1.12 | 0.049 | 0.43 | 0.53 | 0.31 | 0.14 |
Sarcosine | 1.44 | 0.79§ | 0.95§ | 1.49 | 0.83§ | 0.88§ | 0.94 | <0.001 | 0.038 | 0.74 | 0.35 |
dimethylglycine | 0.80 | 1.31§ | 1.43§ | 0.86 | 1.13§ | 1.10§ | 0.23 | <0.001 | 0.16 | 0.62 | 0.03 |
Betaine | 0.46 | 1.15§ | 1.30§ | 0.54 | 1.19§ | 1.37§ | 0.17 | <0.001 | 0.09 | 0.15 | 0.43 |
S-adenosylhomocysteine (SAH) | 0.75# | 1.03 | 0.65 | 1.52# | 1.12§ | 0.98§ | 0.005 | 0.0387 | 0.020 | 0.46 | 0.02 |
TCA Cycle | |||||||||||
Citrate | 0.96 | 0.98 | 1.05§ | 1.11 | 1.09 | 1.02§ | 0.36 | 0.81 | 0.046 | 0.18 | 0.01 |
aconitate [cis or trans] | 0.82# | 1.18§ | 0.95§ | 1.12# | 1.10 | 1.23§ | 0.09 | 0.000 | 0.000 | 0.004 | 0.000 |
alpha-ketoglutarate | 1.11 | 1.11 | 1.35§ | 0.94 | 0.99 | 0.91 | 0.20 | 0.49 | 0.004 | 0.13 | 0.01 |
succinylcarnitine | 1.03 | 0.97 | 1.01 | 1.38 | 1.35 | 1.25 | 0.13 | 0.56 | 0.40 | 0.55 | 0.74 |
Succinate | 1.12# | 1.28 | 1.07 | 0.90# | 0.91 | 1.18§ | 0.08 | 0.53 | 0.12 | 0.012 | 0.008 |
Malate | 1.33 | 1.46 | 1.43 | 0.96 | 0.88 | 0.98 | 0.03 | 0.61 | 0.64 | 0.36 | 0.76 |
Urea Cycle | |||||||||||
Arginine | 1.05 | 1.03 | 1.00 | 1.05 | 1.02 | 1.03 | 0.85 | 0.73 | 0.58 | 0.99 | 0.88 |
argininosuccinate | 0.76 | 0.88 | 0.92 | 1.11 | 1.02 | 0.72§ | 0.59 | 0.39 | 0.63 | 0.10 | 0.03 |
Urea | 0.87# | 0.93§ | 0.91 | 1.48# | 1.31§ | 1.24 | 0.03 | 0.99 | 0.66 | 0.55 | 0.01 |
Ornithine | 0.94 | 0.98 | 1.02 | 1.05 | 1.02 | 1.13 | 0.20 | 0.08 | 0.43 | 0.08 | 0.41 |
Citrulline | 0.95# | 0.88 | 0.85 | 1.30# | 1.19 | 1.08§ | 0.01 | 0.01 | 0.76 | 0.23 | 0.70 |
Arginine and Proline Metabolism | |||||||||||
2-oxoarginine | 0.97 | 1.08 | 1.00 | 0.78 | 0.90 | 0.87 | 0.20 | 0.10 | 0.42 | 0.58 | 0.61 |
Homoarginine | 1.40 | 1.52 | 1.70 | 1.08 | 1.34 | 1.23 | 0.57 | 0.33 | 0.29 | 0.79 | 0.65 |
Homocitrulline | 0.65 | 1.11§ | 1.08§ | 1.22 | 1.89§ | 1.44§ | 0.07 | 0.000 | 0.83 | 0.26 | 0.39 |
Proline | 0.95 | 1.01 | 1.02 | 0.99 | 0.94 | 1.08 | 0.79 | 0.08 | 0.92 | 0.026 | 0.18 |
dimethylarginine (SDMA + ADMA) | 0.88# | 0.91 | 0.93 | 1.20# | 1.21 | 1.14 | 0.002 | 0.77 | 0.56 | 0.82 | 0.52 |
N-acetylarginine | 0.87# | 0.94§ | 0.94§ | 1.17# | 1.16 | 1.11 | 0.01 | 0.14 | 0.93 | 0.71 | 0.01 |
N-delta-acetylornithine | 0.98 | 0.93 | 1.00 | 1.22 | 1.17 | 1.18 | 0.34 | 0.70 | 0.52 | 0.79 | 0.96 |
trans-4-hydroxyproline | 1.12 | 0.93§ | 0.91 | 1.23 | 1.08 | 1.08 | 0.25 | 0.03 | 0.81 | 0.99 | 0.93 |
pro-hydroxy-pro | 1.44 | 0.85§ | 0.92§ | 1.20 | 0.95§ | 0.92§ | 0.73 | 0.000 | 0.25 | 0.88 | 0.03 |
N-methylproline | 1.04 | 1.10 | 0.92 | 1.30 | 1.29 | 1.10 | 0.36 | 0.12 | 0.016 | 0.74 | 0.30 |
N-monomethylarginine | 1.00 | 0.94 | 0.92 | 1.13 | 1.04 | 1.07 | 0.09 | 0.11 | 0.60 | 0.43 | 0.64 |
Argininate | 1.12 | 1.71§ | 1.59§ | 1.30 | 1.64§ | 1.27§ | 0.30 | 0.000 | 0.49 | 0.81 | 0.95 |
1–3, ‡, ¥, # See Table 3.
*For each metabolite, mean value is the group mean of re-scaled data to have median equal to 1.
§The mixed model was used to test whether the difference of two paired observations from a single cat at baseline and the end of the 4 week feeding period was different than zero.
Significance was established when P ≤ 0.05 (for type 1 error) and q ≤ 0.1 (q-values were used to estimate false discovery rate in multiple comparisons).